Mucolytic Drainage Liquescence
Generic Name: mucolytic drainage liquescence
Brand Names:
Mucolytic Drainage Liquescence 3017
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Overview
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Uses
INDICATIONS For the temporary relief of excess mucus or fluid buildup.*
Dosage
DIRECTIONS Place drops under tongue 30 minutes before/after meals. Adults and children 12 years and over: Take one full dropper up to 2 times per day. For immediate onset of symptoms, take 10 to 15 drops every 15 minutes up to 3 hours. For less severe symptoms, take 10-15 drops hourly up to 8 hours. Consult a physician for use in children under 12 years of age.
Warnings
WARNINGS In case of overdose, get medical help or contact a poison control center right away. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
Pregnancy
If pregnant or breastfeeding, ask a healthcare professional before use.
Frequently Asked Questions
What is Mucolytic Drainage Liquescence used for?▼
INDICATIONS For the temporary relief of excess mucus or fluid buildup.*
Can I take Mucolytic Drainage Liquescence during pregnancy?▼
If pregnant or breastfeeding, ask a healthcare professional before use.
What are the important warnings for Mucolytic Drainage Liquescence?▼
WARNINGS In case of overdose, get medical help or contact a poison control center right away. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
Related Medications
Eliglustat Tartrate (amorphous)
eliglustat tartrate (amorphous)
Dosage form: POWDER. Active ingredients: ELIGLUSTAT TARTRATE (1 kg/kg). Category: BULK INGREDIENT.
Pemetrexed Dipotassium Heptahydrate
pemetrexed dipotassium heptahydrate
Dosage form: POWDER. Active ingredients: PEMETREXED (1 kg/kg). Category: BULK INGREDIENT.
Venlafaxine
venlafaxine
DESCRIPTION Venlafaxine tablets, USP is a structurally novel antidepressant for oral administration. It is designated (R/S)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl] cyclohexanol hydrochloride or (±)-1-[α-[(dimethylamino)methyl]-p-methoxybenzyl]cyclohexanol hydrochloride and has the empirical formula of C 17 H 27 NO 2 HCl. Its molecular weight is 313.87. The structural formula is shown below.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.